StonvexLoading…
StonvexStonvexStonvexCore line items from PRSU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $452.42M | $366.49M | $350.29M | $299.33M |
Operating Income | $55.02M | $-45.44M | $108.44M | $68.94M |
Net Income | $22.67M | $368.54M | $16.02M | $23.22M |
EPS (Diluted) | $0.80 | $12.84 | $0.30 | $0.54 |
Total Assets | $965.42M | $845.01M | $1.14B | $1.09B |
Total Liabilities | $305.04M | $228.32M | $867.38M | $855.96M |
Cash & Equivalents | $31.12M | $49.70M | $27.43M | $59.72M |
Free Cash Flow OCF − CapEx | $11.13M | $718.00K | $42.23M | $16.53M |
Shares Outstanding | 28.01M | 28.08M | 28.08M | 24.93M |